Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country save search
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 0.0%
H: 1.07%
C: -2.36%
conference life sciences anavex
Bristol Myers Squibb to Present Data at the American College of Cardiology Annual Scientific Session 2024 Reinforcing Extensive Body of Evidence in Clinical and Real-World Settings Across Cardiovascular Portfolio
Published: 2024-03-25 (Crawled : 13:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.29%
H: 1.27%
C: 0.33%
cardiovascular cardiology
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
CNTX | $1.39 -1.42% -1.44% 5.7K
|
Health Technology
|
| O: 0.87%
H: 6.78%
C: -7.76%
year therapeutics financial results
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
Published: 2024-03-20 (Crawled : 14:00) - biospace.com/
LUCD | $0.7941 -0.61% -0.62% 120K
|
|
| O: -0.93%
H: 3.74%
C: 3.74%
PAVM | $1.95 -1.03% 20K
|
Health Technology
|
| O: 1.95%
H: 14.83%
C: 5.74%
conference disease week diagnostics
Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 3.03%
H: 2.94%
C: 1.47%
patent
Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.33%
H: 1.02%
C: 0.48%
opdivo treatment trial advanced plus
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K
|
Health Technology
|
| O: 10.43%
H: 34.62%
C: 12.69%
announcement disease alzheimer’s update buntanetap study
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
Published: 2024-03-19 (Crawled : 14:00) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 2.72%
H: 10.6%
C: -3.97%
software pharmaceuticals collaboration
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Published: 2024-03-19 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.56%
H: 0.99%
C: -1.3%
report biotech publication
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Published: 2024-03-19 (Crawled : 12:00) - biospace.com/
SSKN | $0.56 5.15% 4.89% 75K
|
Health Technology
|
| O: 1.28%
H: 9.63%
C: -2.2%
avoid family growth
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
KRMD | $2.06 0.0% 59K
|
Health Technology
|
| O: 0.0%
H: 4.09%
C: -5.45%
conference system medical
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.46%
H: 0.23%
C: -1.88%
acquisition
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Published: 2024-03-15 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.27%
H: 4.91%
C: -2.9%
carvykti fda treatment
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Published: 2024-03-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 0.5%
H: 7.98%
C: -3.13%
year financial results
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
Published: 2024-03-15 (Crawled : 11:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: -0.56%
H: 1.75%
C: 1.4%
keytruda cancer alone advanced plus
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
KRMD | $2.06 0.0% 59K
|
Health Technology
|
| O: 0.95%
H: 0.94%
C: 0.0%
year medical financial
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
PGNY | $32.68 2.51% 2.45% 1.1M
|
Commercial Services
|
| O: -0.85%
H: 2.87%
C: 2.16%
conference global
Merck Completes Acquisition of Harpoon Therapeutics, Inc.
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: -1.51%
merck acquisition
Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.47%
C: -3.31%
fibromyalgia pharmaceuticals
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-11 (Crawled : 16:00) - biospace.com/
LXEO | $11.995 -0.62% -0.63% 87K
|
|
| O: 6.87%
H: 0.0%
C: -10.39%
year therapeutics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.